Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

Coronavirus disease-19 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), represents one of the biggest challenges of 21st century, threatening public health around the globe. Increasing age and presence of co-morbidities are reported risk factors for severe disease...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 2021-07, Vol.56 (7), p.1493-1508
Hauptverfasser: Greco, Raffaella, Alexander, Tobias, Burman, Joachim, Del Papa, Nicoletta, de Vries-Bouwstra, Jeska, Farge, Dominique, Henes, Jörg, Kazmi, Majid, Kirgizov, Kirill, Muraro, Paolo A., Ricart, Elena, Rovira, Montserrat, Saccardi, Riccardo, Sharrack, Basil, Snarski, Emilian, Withers, Barbara, Jessop, Helen, Boglione, Claudia, Kramer, Ellen, Badoglio, Manuela, Labopin, Myriam, Orchard, Kim, Corbacioglu, Selim, Ljungman, Per, Mikulska, Malgorzata, De la Camara, Rafael, Snowden, John A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1508
container_issue 7
container_start_page 1493
container_title Bone marrow transplantation (Basingstoke)
container_volume 56
creator Greco, Raffaella
Alexander, Tobias
Burman, Joachim
Del Papa, Nicoletta
de Vries-Bouwstra, Jeska
Farge, Dominique
Henes, Jörg
Kazmi, Majid
Kirgizov, Kirill
Muraro, Paolo A.
Ricart, Elena
Rovira, Montserrat
Saccardi, Riccardo
Sharrack, Basil
Snarski, Emilian
Withers, Barbara
Jessop, Helen
Boglione, Claudia
Kramer, Ellen
Badoglio, Manuela
Labopin, Myriam
Orchard, Kim
Corbacioglu, Selim
Ljungman, Per
Mikulska, Malgorzata
De la Camara, Rafael
Snowden, John A.
description Coronavirus disease-19 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), represents one of the biggest challenges of 21st century, threatening public health around the globe. Increasing age and presence of co-morbidities are reported risk factors for severe disease and mortality, along with autoimmune diseases (ADs) and immunosuppressive treatments such as haematopoietic stem cell transplantation (HSCT), which are also associated with adverse outcomes. We review the impact of the pandemic on specific groups of patients with neurological, rheumatological, and gastroenterological indications, along with the challenges delivering HSCT in adult and pediatric populations. Moving forward, we developed consensus-based guidelines and recommendations for best practice and quality of patient care in order to support clinicians, scientists, and their multidisciplinary teams, as well as patients and their carers. These guidelines aim to support national and international organizations related to autoimmune diseases and local clinical teams delivering HSCT. Areas of unmet need and future research questions are also highlighted. The waves of the COVID-19 pandemic are predicted to be followed by an “endemic” phase and therefore an ongoing risk within a “new normality”. These recommendations reflect currently available evidence, coupled with expert opinion, and will be revised according to necessary modifications in practice.
doi_str_mv 10.1038/s41409-021-01326-6
format Article
fullrecord <record><control><sourceid>gale_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_461787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A667741636</galeid><sourcerecordid>A667741636</sourcerecordid><originalsourceid>FETCH-LOGICAL-c647t-fda19c75f77de956ba92bfd42df5033731315490f0b46cace193a0511a81c94c3</originalsourceid><addsrcrecordid>eNp9kktv1DAUhSMEokPhD7BAlpAQC1Ls-JGEBdIwLbRSUTelW8vj3My4xPZgOyAkfjyeB0MHAfIikf2dY_ncUxRPCT4hmDavIyMMtyWuSIkJrUQp7hUTwmpRcir4_WKCK9GUlIr2qHgU4y3GhDHMHxZHlGFKOBeT4sc5WJX8yhtIRqOYwCINw4BSUC6uBuWSSsY71PuA1Ji8sXZ0gDoTQUWIyDiUloCSsYB8j2ZXNxenJWnfoLN3H6_RYjQdDMZlULkOBdDeWnDdxjM-Lh70aojwZPc9Lj69P7uenZeXVx8uZtPLUgtWp7LvFGl1zfu67qDlYq7aat53rOp6jimtKcmPYS3u8ZwJrTSQlirMCVEN0S3T9Lgot77xG6zGuVwFY1X4Lr0ycrf1Of-BZILUTZ35V__kT83NVPqwkOMoGWe8YRl_u8Uza6HT4HJ4w4Hq8MSZpVz4r7IhjGLeZoOXO4Pgv4wQk7QmrqegHPgxyorTqmIir4w-_wO99WNwOb1M5QxyFJneUws1gDSu9_levTaVUyHqmhFBRaZO_kLl1YE12jvoTd4_ELy4I1iCGtIy-mHcDPMQrLagDj7GAP0-DILlurty212Zuys33ZVr0bO7Me4lv8qaAbobSz5yCwi_3_4f25_Cv_ls</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2549013125</pqid></control><display><type>article</type><title>Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SWEPUB Freely available online</source><creator>Greco, Raffaella ; Alexander, Tobias ; Burman, Joachim ; Del Papa, Nicoletta ; de Vries-Bouwstra, Jeska ; Farge, Dominique ; Henes, Jörg ; Kazmi, Majid ; Kirgizov, Kirill ; Muraro, Paolo A. ; Ricart, Elena ; Rovira, Montserrat ; Saccardi, Riccardo ; Sharrack, Basil ; Snarski, Emilian ; Withers, Barbara ; Jessop, Helen ; Boglione, Claudia ; Kramer, Ellen ; Badoglio, Manuela ; Labopin, Myriam ; Orchard, Kim ; Corbacioglu, Selim ; Ljungman, Per ; Mikulska, Malgorzata ; De la Camara, Rafael ; Snowden, John A.</creator><creatorcontrib>Greco, Raffaella ; Alexander, Tobias ; Burman, Joachim ; Del Papa, Nicoletta ; de Vries-Bouwstra, Jeska ; Farge, Dominique ; Henes, Jörg ; Kazmi, Majid ; Kirgizov, Kirill ; Muraro, Paolo A. ; Ricart, Elena ; Rovira, Montserrat ; Saccardi, Riccardo ; Sharrack, Basil ; Snarski, Emilian ; Withers, Barbara ; Jessop, Helen ; Boglione, Claudia ; Kramer, Ellen ; Badoglio, Manuela ; Labopin, Myriam ; Orchard, Kim ; Corbacioglu, Selim ; Ljungman, Per ; Mikulska, Malgorzata ; De la Camara, Rafael ; Snowden, John A. ; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee ; On behalf of the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee</creatorcontrib><description>Coronavirus disease-19 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), represents one of the biggest challenges of 21st century, threatening public health around the globe. Increasing age and presence of co-morbidities are reported risk factors for severe disease and mortality, along with autoimmune diseases (ADs) and immunosuppressive treatments such as haematopoietic stem cell transplantation (HSCT), which are also associated with adverse outcomes. We review the impact of the pandemic on specific groups of patients with neurological, rheumatological, and gastroenterological indications, along with the challenges delivering HSCT in adult and pediatric populations. Moving forward, we developed consensus-based guidelines and recommendations for best practice and quality of patient care in order to support clinicians, scientists, and their multidisciplinary teams, as well as patients and their carers. These guidelines aim to support national and international organizations related to autoimmune diseases and local clinical teams delivering HSCT. Areas of unmet need and future research questions are also highlighted. The waves of the COVID-19 pandemic are predicted to be followed by an “endemic” phase and therefore an ongoing risk within a “new normality”. These recommendations reflect currently available evidence, coupled with expert opinion, and will be revised according to necessary modifications in practice.</description><identifier>ISSN: 0268-3369</identifier><identifier>ISSN: 1476-5365</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/s41409-021-01326-6</identifier><identifier>PMID: 34031556</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/1503/257 ; 692/699/1670 ; 692/699/255 ; 692/699/375 ; 692/700/565/251 ; Adult ; Autoimmune diseases ; Autoimmune Diseases - therapy ; Best practice ; Bone marrow ; Care and treatment ; Cell Biology ; Child ; Control ; Coronaviruses ; COVID-19 ; Epidemics ; Europe ; Feature ; Guidelines ; Health risks ; Hematology ; Hematopoietic Stem Cell Transplantation ; Hematopoietic stem cells ; Humans ; Internal Medicine ; International organizations ; Medicine ; Medicine &amp; Public Health ; Pandemics ; Patients ; Public Health ; Respiratory diseases ; Risk analysis ; Risk factors ; SARS-CoV-2 ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Stem cell transplantation ; Stem Cells ; Teams ; Transplantation ; Viral diseases</subject><ispartof>Bone marrow transplantation (Basingstoke), 2021-07, Vol.56 (7), p.1493-1508</ispartof><rights>The Author(s) 2021</rights><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c647t-fda19c75f77de956ba92bfd42df5033731315490f0b46cace193a0511a81c94c3</citedby><cites>FETCH-LOGICAL-c647t-fda19c75f77de956ba92bfd42df5033731315490f0b46cace193a0511a81c94c3</cites><orcidid>0000-0003-4514-4748 ; 0000-0003-3226-2024 ; 0000-0002-8189-5779 ; 0000-0003-2700-7571 ; 0000-0001-6819-3476 ; 0000-0002-3822-1218 ; 0000-0002-7045-1806 ; 0000-0002-8281-3245 ; 0000-0003-1193-0097 ; 0000-0002-6117-5328</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41409-021-01326-6$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41409-021-01326-6$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,550,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34031556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-454584$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:146730994$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Greco, Raffaella</creatorcontrib><creatorcontrib>Alexander, Tobias</creatorcontrib><creatorcontrib>Burman, Joachim</creatorcontrib><creatorcontrib>Del Papa, Nicoletta</creatorcontrib><creatorcontrib>de Vries-Bouwstra, Jeska</creatorcontrib><creatorcontrib>Farge, Dominique</creatorcontrib><creatorcontrib>Henes, Jörg</creatorcontrib><creatorcontrib>Kazmi, Majid</creatorcontrib><creatorcontrib>Kirgizov, Kirill</creatorcontrib><creatorcontrib>Muraro, Paolo A.</creatorcontrib><creatorcontrib>Ricart, Elena</creatorcontrib><creatorcontrib>Rovira, Montserrat</creatorcontrib><creatorcontrib>Saccardi, Riccardo</creatorcontrib><creatorcontrib>Sharrack, Basil</creatorcontrib><creatorcontrib>Snarski, Emilian</creatorcontrib><creatorcontrib>Withers, Barbara</creatorcontrib><creatorcontrib>Jessop, Helen</creatorcontrib><creatorcontrib>Boglione, Claudia</creatorcontrib><creatorcontrib>Kramer, Ellen</creatorcontrib><creatorcontrib>Badoglio, Manuela</creatorcontrib><creatorcontrib>Labopin, Myriam</creatorcontrib><creatorcontrib>Orchard, Kim</creatorcontrib><creatorcontrib>Corbacioglu, Selim</creatorcontrib><creatorcontrib>Ljungman, Per</creatorcontrib><creatorcontrib>Mikulska, Malgorzata</creatorcontrib><creatorcontrib>De la Camara, Rafael</creatorcontrib><creatorcontrib>Snowden, John A.</creatorcontrib><creatorcontrib>European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee</creatorcontrib><creatorcontrib>On behalf of the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee</creatorcontrib><title>Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><addtitle>Bone Marrow Transplant</addtitle><description>Coronavirus disease-19 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), represents one of the biggest challenges of 21st century, threatening public health around the globe. Increasing age and presence of co-morbidities are reported risk factors for severe disease and mortality, along with autoimmune diseases (ADs) and immunosuppressive treatments such as haematopoietic stem cell transplantation (HSCT), which are also associated with adverse outcomes. We review the impact of the pandemic on specific groups of patients with neurological, rheumatological, and gastroenterological indications, along with the challenges delivering HSCT in adult and pediatric populations. Moving forward, we developed consensus-based guidelines and recommendations for best practice and quality of patient care in order to support clinicians, scientists, and their multidisciplinary teams, as well as patients and their carers. These guidelines aim to support national and international organizations related to autoimmune diseases and local clinical teams delivering HSCT. Areas of unmet need and future research questions are also highlighted. The waves of the COVID-19 pandemic are predicted to be followed by an “endemic” phase and therefore an ongoing risk within a “new normality”. These recommendations reflect currently available evidence, coupled with expert opinion, and will be revised according to necessary modifications in practice.</description><subject>692/699/1503/257</subject><subject>692/699/1670</subject><subject>692/699/255</subject><subject>692/699/375</subject><subject>692/700/565/251</subject><subject>Adult</subject><subject>Autoimmune diseases</subject><subject>Autoimmune Diseases - therapy</subject><subject>Best practice</subject><subject>Bone marrow</subject><subject>Care and treatment</subject><subject>Cell Biology</subject><subject>Child</subject><subject>Control</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Epidemics</subject><subject>Europe</subject><subject>Feature</subject><subject>Guidelines</subject><subject>Health risks</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Hematopoietic stem cells</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>International organizations</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Public Health</subject><subject>Respiratory diseases</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Stem cell transplantation</subject><subject>Stem Cells</subject><subject>Teams</subject><subject>Transplantation</subject><subject>Viral diseases</subject><issn>0268-3369</issn><issn>1476-5365</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>D8T</sourceid><recordid>eNp9kktv1DAUhSMEokPhD7BAlpAQC1Ls-JGEBdIwLbRSUTelW8vj3My4xPZgOyAkfjyeB0MHAfIikf2dY_ncUxRPCT4hmDavIyMMtyWuSIkJrUQp7hUTwmpRcir4_WKCK9GUlIr2qHgU4y3GhDHMHxZHlGFKOBeT4sc5WJX8yhtIRqOYwCINw4BSUC6uBuWSSsY71PuA1Ji8sXZ0gDoTQUWIyDiUloCSsYB8j2ZXNxenJWnfoLN3H6_RYjQdDMZlULkOBdDeWnDdxjM-Lh70aojwZPc9Lj69P7uenZeXVx8uZtPLUgtWp7LvFGl1zfu67qDlYq7aat53rOp6jimtKcmPYS3u8ZwJrTSQlirMCVEN0S3T9Lgot77xG6zGuVwFY1X4Lr0ycrf1Of-BZILUTZ35V__kT83NVPqwkOMoGWe8YRl_u8Uza6HT4HJ4w4Hq8MSZpVz4r7IhjGLeZoOXO4Pgv4wQk7QmrqegHPgxyorTqmIir4w-_wO99WNwOb1M5QxyFJneUws1gDSu9_levTaVUyHqmhFBRaZO_kLl1YE12jvoTd4_ELy4I1iCGtIy-mHcDPMQrLagDj7GAP0-DILlurty212Zuys33ZVr0bO7Me4lv8qaAbobSz5yCwi_3_4f25_Cv_ls</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Greco, Raffaella</creator><creator>Alexander, Tobias</creator><creator>Burman, Joachim</creator><creator>Del Papa, Nicoletta</creator><creator>de Vries-Bouwstra, Jeska</creator><creator>Farge, Dominique</creator><creator>Henes, Jörg</creator><creator>Kazmi, Majid</creator><creator>Kirgizov, Kirill</creator><creator>Muraro, Paolo A.</creator><creator>Ricart, Elena</creator><creator>Rovira, Montserrat</creator><creator>Saccardi, Riccardo</creator><creator>Sharrack, Basil</creator><creator>Snarski, Emilian</creator><creator>Withers, Barbara</creator><creator>Jessop, Helen</creator><creator>Boglione, Claudia</creator><creator>Kramer, Ellen</creator><creator>Badoglio, Manuela</creator><creator>Labopin, Myriam</creator><creator>Orchard, Kim</creator><creator>Corbacioglu, Selim</creator><creator>Ljungman, Per</creator><creator>Mikulska, Malgorzata</creator><creator>De la Camara, Rafael</creator><creator>Snowden, John A.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>ACNBI</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DF2</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0003-4514-4748</orcidid><orcidid>https://orcid.org/0000-0003-3226-2024</orcidid><orcidid>https://orcid.org/0000-0002-8189-5779</orcidid><orcidid>https://orcid.org/0000-0003-2700-7571</orcidid><orcidid>https://orcid.org/0000-0001-6819-3476</orcidid><orcidid>https://orcid.org/0000-0002-3822-1218</orcidid><orcidid>https://orcid.org/0000-0002-7045-1806</orcidid><orcidid>https://orcid.org/0000-0002-8281-3245</orcidid><orcidid>https://orcid.org/0000-0003-1193-0097</orcidid><orcidid>https://orcid.org/0000-0002-6117-5328</orcidid></search><sort><creationdate>20210701</creationdate><title>Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations</title><author>Greco, Raffaella ; Alexander, Tobias ; Burman, Joachim ; Del Papa, Nicoletta ; de Vries-Bouwstra, Jeska ; Farge, Dominique ; Henes, Jörg ; Kazmi, Majid ; Kirgizov, Kirill ; Muraro, Paolo A. ; Ricart, Elena ; Rovira, Montserrat ; Saccardi, Riccardo ; Sharrack, Basil ; Snarski, Emilian ; Withers, Barbara ; Jessop, Helen ; Boglione, Claudia ; Kramer, Ellen ; Badoglio, Manuela ; Labopin, Myriam ; Orchard, Kim ; Corbacioglu, Selim ; Ljungman, Per ; Mikulska, Malgorzata ; De la Camara, Rafael ; Snowden, John A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c647t-fda19c75f77de956ba92bfd42df5033731315490f0b46cace193a0511a81c94c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>692/699/1503/257</topic><topic>692/699/1670</topic><topic>692/699/255</topic><topic>692/699/375</topic><topic>692/700/565/251</topic><topic>Adult</topic><topic>Autoimmune diseases</topic><topic>Autoimmune Diseases - therapy</topic><topic>Best practice</topic><topic>Bone marrow</topic><topic>Care and treatment</topic><topic>Cell Biology</topic><topic>Child</topic><topic>Control</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Epidemics</topic><topic>Europe</topic><topic>Feature</topic><topic>Guidelines</topic><topic>Health risks</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Hematopoietic stem cells</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>International organizations</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Public Health</topic><topic>Respiratory diseases</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Stem cell transplantation</topic><topic>Stem Cells</topic><topic>Teams</topic><topic>Transplantation</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Greco, Raffaella</creatorcontrib><creatorcontrib>Alexander, Tobias</creatorcontrib><creatorcontrib>Burman, Joachim</creatorcontrib><creatorcontrib>Del Papa, Nicoletta</creatorcontrib><creatorcontrib>de Vries-Bouwstra, Jeska</creatorcontrib><creatorcontrib>Farge, Dominique</creatorcontrib><creatorcontrib>Henes, Jörg</creatorcontrib><creatorcontrib>Kazmi, Majid</creatorcontrib><creatorcontrib>Kirgizov, Kirill</creatorcontrib><creatorcontrib>Muraro, Paolo A.</creatorcontrib><creatorcontrib>Ricart, Elena</creatorcontrib><creatorcontrib>Rovira, Montserrat</creatorcontrib><creatorcontrib>Saccardi, Riccardo</creatorcontrib><creatorcontrib>Sharrack, Basil</creatorcontrib><creatorcontrib>Snarski, Emilian</creatorcontrib><creatorcontrib>Withers, Barbara</creatorcontrib><creatorcontrib>Jessop, Helen</creatorcontrib><creatorcontrib>Boglione, Claudia</creatorcontrib><creatorcontrib>Kramer, Ellen</creatorcontrib><creatorcontrib>Badoglio, Manuela</creatorcontrib><creatorcontrib>Labopin, Myriam</creatorcontrib><creatorcontrib>Orchard, Kim</creatorcontrib><creatorcontrib>Corbacioglu, Selim</creatorcontrib><creatorcontrib>Ljungman, Per</creatorcontrib><creatorcontrib>Mikulska, Malgorzata</creatorcontrib><creatorcontrib>De la Camara, Rafael</creatorcontrib><creatorcontrib>Snowden, John A.</creatorcontrib><creatorcontrib>European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee</creatorcontrib><creatorcontrib>On behalf of the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Uppsala universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Uppsala universitet</collection><collection>SwePub Articles full text</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Greco, Raffaella</au><au>Alexander, Tobias</au><au>Burman, Joachim</au><au>Del Papa, Nicoletta</au><au>de Vries-Bouwstra, Jeska</au><au>Farge, Dominique</au><au>Henes, Jörg</au><au>Kazmi, Majid</au><au>Kirgizov, Kirill</au><au>Muraro, Paolo A.</au><au>Ricart, Elena</au><au>Rovira, Montserrat</au><au>Saccardi, Riccardo</au><au>Sharrack, Basil</au><au>Snarski, Emilian</au><au>Withers, Barbara</au><au>Jessop, Helen</au><au>Boglione, Claudia</au><au>Kramer, Ellen</au><au>Badoglio, Manuela</au><au>Labopin, Myriam</au><au>Orchard, Kim</au><au>Corbacioglu, Selim</au><au>Ljungman, Per</au><au>Mikulska, Malgorzata</au><au>De la Camara, Rafael</au><au>Snowden, John A.</au><aucorp>European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee</aucorp><aucorp>On behalf of the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><stitle>Bone Marrow Transplant</stitle><addtitle>Bone Marrow Transplant</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>56</volume><issue>7</issue><spage>1493</spage><epage>1508</epage><pages>1493-1508</pages><issn>0268-3369</issn><issn>1476-5365</issn><eissn>1476-5365</eissn><abstract>Coronavirus disease-19 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), represents one of the biggest challenges of 21st century, threatening public health around the globe. Increasing age and presence of co-morbidities are reported risk factors for severe disease and mortality, along with autoimmune diseases (ADs) and immunosuppressive treatments such as haematopoietic stem cell transplantation (HSCT), which are also associated with adverse outcomes. We review the impact of the pandemic on specific groups of patients with neurological, rheumatological, and gastroenterological indications, along with the challenges delivering HSCT in adult and pediatric populations. Moving forward, we developed consensus-based guidelines and recommendations for best practice and quality of patient care in order to support clinicians, scientists, and their multidisciplinary teams, as well as patients and their carers. These guidelines aim to support national and international organizations related to autoimmune diseases and local clinical teams delivering HSCT. Areas of unmet need and future research questions are also highlighted. The waves of the COVID-19 pandemic are predicted to be followed by an “endemic” phase and therefore an ongoing risk within a “new normality”. These recommendations reflect currently available evidence, coupled with expert opinion, and will be revised according to necessary modifications in practice.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>34031556</pmid><doi>10.1038/s41409-021-01326-6</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0003-4514-4748</orcidid><orcidid>https://orcid.org/0000-0003-3226-2024</orcidid><orcidid>https://orcid.org/0000-0002-8189-5779</orcidid><orcidid>https://orcid.org/0000-0003-2700-7571</orcidid><orcidid>https://orcid.org/0000-0001-6819-3476</orcidid><orcidid>https://orcid.org/0000-0002-3822-1218</orcidid><orcidid>https://orcid.org/0000-0002-7045-1806</orcidid><orcidid>https://orcid.org/0000-0002-8281-3245</orcidid><orcidid>https://orcid.org/0000-0003-1193-0097</orcidid><orcidid>https://orcid.org/0000-0002-6117-5328</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-3369
ispartof Bone marrow transplantation (Basingstoke), 2021-07, Vol.56 (7), p.1493-1508
issn 0268-3369
1476-5365
1476-5365
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_461787
source MEDLINE; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SWEPUB Freely available online
subjects 692/699/1503/257
692/699/1670
692/699/255
692/699/375
692/700/565/251
Adult
Autoimmune diseases
Autoimmune Diseases - therapy
Best practice
Bone marrow
Care and treatment
Cell Biology
Child
Control
Coronaviruses
COVID-19
Epidemics
Europe
Feature
Guidelines
Health risks
Hematology
Hematopoietic Stem Cell Transplantation
Hematopoietic stem cells
Humans
Internal Medicine
International organizations
Medicine
Medicine & Public Health
Pandemics
Patients
Public Health
Respiratory diseases
Risk analysis
Risk factors
SARS-CoV-2
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Stem cell transplantation
Stem Cells
Teams
Transplantation
Viral diseases
title Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T02%3A16%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hematopoietic%20stem%20cell%20transplantation%20for%20autoimmune%20diseases%20in%20the%20time%20of%20COVID-19:%20EBMT%20guidelines%20and%20recommendations&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=Greco,%20Raffaella&rft.aucorp=European%20Society%20for%20Blood%20and%20Marrow%20Transplantation%20(EBMT)%20Autoimmune%20Diseases%20Working%20Party%20(ADWP),%20Infectious%20Diseases%20Working%20Party%20(IDWP),%20Pediatric%20Working%20Party%20(PWP),%20Joint%20Accreditation%20Committee%20of%20the%20International%20Society%20for%20Cellular%20Therapy%20(ISCT)%20and%20EBMT%20(JACIE),%20EBMT%20Nurses%20Group%20and%20Patient%20Advocacy%20Committee&rft.date=2021-07-01&rft.volume=56&rft.issue=7&rft.spage=1493&rft.epage=1508&rft.pages=1493-1508&rft.issn=0268-3369&rft.eissn=1476-5365&rft_id=info:doi/10.1038/s41409-021-01326-6&rft_dat=%3Cgale_swepu%3EA667741636%3C/gale_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2549013125&rft_id=info:pmid/34031556&rft_galeid=A667741636&rfr_iscdi=true